CHEBI:3651 - chlorprothixene

ChEBI IDCHEBI:3651
ChEBI Namechlorprothixene
Stars
Last Modified23 September 2021
DownloadsMolfile
FormulaC18H18ClNS
Net Charge0
Average Mass315.869
Monoisotopic Mass315.08485
SMILES[H]C(CCN(C)C)=C1c2ccccc2Sc2ccc(Cl)cc21
InChIInChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3
InChIKeyWSPOMRSOLSGNFJ-UHFFFAOYSA-N
Roles Classification
Chemical Role:
Bronsted base  A molecular entity capable of accepting a hydron from a donor (Brønsted acid).
Biological Roles:
dopaminergic antagonist  A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
cholinergic antagonist  Any drug that binds to but does not activate cholinergic receptors, thereby blocking the actions of acetylcholine or cholinergic agonists.
non-narcotic analgesic  A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
Applications:
antiemetic  A drug used to prevent nausea or vomiting. An antiemetic may act by a wide range of mechanisms: it might affect the medullary control centres (the vomiting centre and the chemoreceptive trigger zone) or affect the peripheral receptors.
dopaminergic antagonist  A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
first generation antipsychotic  Antipsychotic drugs which can have different modes of action but which tend to be more likely than second generation antipsychotics to cause extrapyramidal motor control disabilities such as body rigidity or Parkinson's disease-type movements; such body movements can become permanent even after treatment has ceased.
cholinergic antagonist  Any drug that binds to but does not activate cholinergic receptors, thereby blocking the actions of acetylcholine or cholinergic agonists.
non-narcotic analgesic  A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
sedative  A central nervous system depressant used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.
ChEBI Ontology
Outgoing Relation(s)
chlorprothixene (CHEBI:3651) has role antiemetic (CHEBI:50919)
chlorprothixene (CHEBI:3651) has role cholinergic antagonist (CHEBI:48873)
chlorprothixene (CHEBI:3651) has role dopaminergic antagonist (CHEBI:48561)
chlorprothixene (CHEBI:3651) has role first generation antipsychotic (CHEBI:65190)
chlorprothixene (CHEBI:3651) has role non-narcotic analgesic (CHEBI:35481)
chlorprothixene (CHEBI:3651) has role sedative (CHEBI:35717)
chlorprothixene (CHEBI:3651) is a organochlorine compound (CHEBI:36683)
chlorprothixene (CHEBI:3651) is a tertiary amino compound (CHEBI:50996)
chlorprothixene (CHEBI:3651) is a thioxanthenes (CHEBI:50930)
chlorprothixene (CHEBI:3651) is conjugate base of chlorprothixene(1+) (CHEBI:180503)
Incoming Relation(s)
(E)-chlorprothixene (CHEBI:50932) is a chlorprothixene (CHEBI:3651)
(Z)-chlorprothixene (CHEBI:50931) is a chlorprothixene (CHEBI:3651)
chlorprothixene(1+) (CHEBI:180503) is conjugate acid of chlorprothixene (CHEBI:3651)
IUPAC Name 
3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine
INNs  Source
chlorprothixeneChEBI
chlorprothixèneChEBI
clorprotixenoChEBI
chlorprothixenumChEBI
Synonyms  Source
ChlorprothixeneKEGG COMPOUND
Alpha-ChlorprothixeneDrugBank
ChlorprothixenDrugBank
ChlorprothixineDrugBank
ChlorprotixenDrugBank
ChlorprotixeneDrugBank
Manual XrefsDatabases
C07953KEGG COMPOUND
D00790KEGG DRUG
GB829763Patent
US3046283Patent
DB01239DrugBank
LSM-3310LINCS
HMDB0015369HMDB
Registry NumbersSources
Beilstein:89898Beilstein